Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1976 1
1977 1
1978 2
1980 1
1981 1
1983 4
1984 4
1985 6
1986 7
1987 7
1988 3
1989 8
1990 10
1991 11
1992 5
1993 6
1994 14
1995 8
1996 14
1997 9
1998 14
1999 20
2000 10
2001 12
2002 16
2003 15
2004 14
2005 14
2006 8
2007 17
2008 17
2009 15
2010 12
2011 21
2012 14
2013 11
2014 8
2015 5
2016 4
2017 7
2018 7
2019 9
2020 10
2021 8
2022 1
2023 10
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Results by year

Filters applied: . Clear all
Page 1
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, Pockros PJ, Regula J, Beuers U, Trauner M, Jones DE, Floreani A, Hohenester S, Luketic V, Shiffman M, van Erpecum KJ, Vargas V, Vincent C, Hirschfield GM, Shah H, Hansen B, Lindor KD, Marschall HU, Kowdley KV, Hooshmand-Rad R, Marmon T, Sheeron S, Pencek R, MacConell L, Pruzanski M, Shapiro D; POISE Study Group. Nevens F, et al. N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840. N Engl J Med. 2016. PMID: 27532829 Free article. Clinical Trial.
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.
Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, Gitlin N, Gordon SC, Odin JA, Sheridan D, Wörns MA, Clark V, Corless L, Hartmann H, Jonas ME, Kremer AE, Mells GF, Buggisch P, Freilich BL, Levy C, Vierling JM, Bernstein DE, Hartleb M, Janczewska E, Rochling F, Shah H, Shiffman ML, Smith JH, Choi YJ, Steinberg A, Varga M, Chera H, Martin R, McWherter CA, Hirschfield GM. Jones D, et al. Among authors: bacon br. Lancet Gastroenterol Hepatol. 2017 Oct;2(10):716-726. doi: 10.1016/S2468-1253(17)30246-7. Epub 2017 Aug 14. Lancet Gastroenterol Hepatol. 2017. PMID: 28818518 Clinical Trial.
Measurement of hepatic iron concentration.
Bacon BR. Bacon BR. Clin Gastroenterol Hepatol. 2015 Jan;13(1):64-5. doi: 10.1016/j.cgh.2014.09.003. Epub 2014 Sep 15. Clin Gastroenterol Hepatol. 2015. PMID: 25220938 No abstract available.
Bacterial Heme-Based Sensors of Nitric Oxide.
Williams DE, Nisbett LM, Bacon B, Boon E. Williams DE, et al. Among authors: bacon b. Antioxid Redox Signal. 2018 Dec 20;29(18):1872-1887. doi: 10.1089/ars.2017.7235. Epub 2017 Sep 28. Antioxid Redox Signal. 2018. PMID: 28847157 Free PMC article. Review.
Screening for hemochromatosis.
Bacon BR. Bacon BR. Arch Intern Med. 2006 Feb 13;166(3):269-70. doi: 10.1001/archinte.166.3.269. Arch Intern Med. 2006. PMID: 16476865 No abstract available.
Hemochromatosis.
Bacon BR. Bacon BR. Curr Treat Options Gastroenterol. 1999 Feb;2(1):58-60. doi: 10.1007/s11938-999-0019-0. Curr Treat Options Gastroenterol. 1999. PMID: 11096573
Nonalcoholic steatohepatitis.
Neuschwander-Tetri BA, Bacon BR. Neuschwander-Tetri BA, et al. Among authors: bacon br. Med Clin North Am. 1996 Sep;80(5):1147-66. doi: 10.1016/s0025-7125(05)70483-1. Med Clin North Am. 1996. PMID: 8804378 Review.
406 results